A pitch deck made by t-able.co for Pepgene, a Korean biotech startup that makes customized PG tags for the mass production of peptides for biosimilars.

2. the future
of medicine
is biological

3. but biologics
are expensive
and cost up to
than generic
alternatives
MORE

4. biosimilars can solve this
problem as biologics
patents expire

5. but biosimilars needs to be both
AFFORDABLE and EFFECTIVE

6. developing cost-effective, high yield
biosimilar production technologies

7. we produce high peptide yields
using PG TAGS and HYPEP TECHNOLOGY

8. we tag our peptides so enzymes can’t break them down

9. then we remove the tags in two stages and
refine the peptides at a rate of 70%

10. OUR TEAM

11. our patented PG TAGS are smaller and more efficient
About
About 6 peptides/cell
About 3 peptides/cell

12. we have made good progress
tag and method
patents
research
cooperation
government
funding

13. and we are going to do more in the future

14. but we need INVESTMENT and PARTNERS
to make our biosimilars a reality